Monsey, NY, United States of America

Vinayak J Srinivasan

This inventor holds 1 USPTO granted patent. Top assignee: Euro-Celtique S.a.. Active years: 2006.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Vinayak J Srinivasan. Retrieved from https://idiyas.com/inventor/vinayak-j-srinivasan

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 14(Granted Patents)


Company Filing History:


Years Active: 2006

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Vinayak J Srinivasan: Innovator in Analgesic Compounds

Introduction

Vinayak J Srinivasan is a notable inventor based in Monsey, NY (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of analgesic compounds. His work focuses on innovative solutions for pain management and related medical conditions.

Latest Patents

Vinayak holds a patent for N-but-3-enyl norbuprenorphine and its use as an analgesic. This invention provides a compound with specific structural properties and includes pharmaceutically acceptable salts or derivatives. The patent outlines methods for preventing and treating pain, inducing sedation, addressing opiate addiction, managing opiate withdrawal, and treating cough in patients.

Career Highlights

Vinayak is associated with Euro-Celtique S.a., where he applies his expertise in pharmaceutical innovation. His work has led to advancements in pain management therapies, showcasing his commitment to improving patient care through scientific research.

Collaborations

He collaborates with notable colleagues, including Bruce Reidenberg and Donna-Donigi Gale, to further enhance the impact of his inventions in the medical field.

Conclusion

Vinayak J Srinivasan's contributions to analgesic compounds represent a significant advancement in pain management. His innovative approach and dedication to research continue to influence the pharmaceutical industry positively.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…